NCT05072015View on ClinicalTrials.gov

Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)

Not yet recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

February 28, 2022

Study Completion Date

March 31, 2028

Conditions

Parkinson's Disease

Trial Locations (1)

67098

Mathieu ANHEIM, Strasbourg

All Listed Sponsors

lead

University Hospital, Strasbourg, France

OTHER